Skip to main content
. 2010 Dec;25(6):601–613. doi: 10.1089/cbr.2010.0865

FIG. 1.

FIG. 1.

T-cell activation and mechanism of action of ipilimumab (adapted with permission from Weber51). APC, antigen presenting cell; CTLA-4, cytotoxic T lymphocyte antigen-4; TCR, T-cell receptor; MHC, major histocompatibility complex.